✦ LIBER ✦

A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer

✍ Scribed by Harold A. Harvey; Richard J. Santen; Juraj Osterman; Eugeniusz Samojlik; Deborah S. White; Allan Lipton

Publisher: John Wiley and Sons
Year: 1979
Tongue: English
Weight: 647 KB
Volume: 43
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197906)43:6<2207::aid-cncr2820430608>3.0.co;2-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of hypophysectomy on the cort

The effect of hypophysectomy on the cortisol secretion in 4 patients with advanced metastatic breast cancer

✍ A. A. M. Lewis; N. Deshpande 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

A randomized comparative trial of combin

A randomized comparative trial of combined versus alternating therapy with cytostatic drugs and high-dose medroxyprogesteron acetate in advanced breast cancer

✍ Jacques A. Wils; Hein Bron; Leo Van Lange; Martin Pannebakker; Anton Romme; Herm 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Comparative trial of low-dose adriamycin

Comparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer

✍ Richard E. Lloyd; Stephen E. Jones; Sydney E. Salmon 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Aminoglutethimide and medroxyprogesteron

Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer: A phase II study of the association of medical oncology of the German cancer society (AIO)

✍ Hans-Erik Wander; Gerd Arno Nagel; Hans-Christian Blossey; Ulrich Kleeberg 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

Treatment of advanced ovarian cancer: A

Treatment of advanced ovarian cancer: A randomised trial comparing adriamycin or 4′epi-adriamycin in combination with cisplatin and cyclophosphamide

✍ Bezwoda, W. R. 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB

Fifty-one patients with ovarian cancer were tients with < 2 cm residual disease had sigentered in a randomised trial comparing treat-nificantly higher rate of complete remission rnent with cisplatin + adriamycin + cyclo-than those with > 2 crn residual disease. Carphosphamide (PAC) to cisplatin + 4'

Phase 2 randomized trial of primary endo

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer

✍ Vladimir F. Semiglazov; Vladislav V. Semiglazov; Garik A. Dashyan; Elena K. Zilt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. Few studies have compared primary neoadjuvant endocrine therapy with neoadjuvant chemotherapy in breast cancer patients. The need for preoperative chemotherapy with doxorubicin or taxanes may be reduced in postmenopausal patients with estrogen receptor (ER)‐positive and/